Literature DB >> 17060026

Mice deficient in PKC theta demonstrate impaired in vivo T cell activation and protection from T cell-mediated inflammatory diseases.

Karen Anderson1, Michael Fitzgerald, Michelle Dupont, Tao Wang, Nancy Paz, Marion Dorsch, Aileen Healy, Yajun Xu, Tim Ocain, Lisa Schopf, Bruce Jaffee, Dominic Picarella.   

Abstract

In the present study we have characterized T cell-driven immune function in mice that are genetically deficient in PKC theta. In response to simple immunologic stimulation invoked by in vivo T cell receptor (TCR) cross-linking, these mice showed significantly depressed plasma cytokine levels for IL-2, IL-4, IFNgamma, and TNFalpha compared to wild-type (WT) mice. In parallel, spleen mRNA levels for these cytokines were reduced, and NF-kappaB activation was also reduced in PKC theta knockouts (KO). Injection of allogeneic cells into the footpad of PKC theta deficient mice provoked a significantly diminished local T cell response compared to WT mice similarly challenged. Unlike comparable cells from wild type mice, CD45RBhi T cells harvested from PKC theta deficient mice failed to induce colitis in the SCID-CD45RB cell transfer model of IBD. In another T cell-dependent model of inflammatory disease, PKC theta deficient animals developed far less severe neurologic signs and reduced spinal cord inflammatory cell infiltrate compared to WT controls in the MOG-induced EAE model. A fundamental role for PKC theta in T cell activation and in the development of T cell-mediated inflammatory diseases is indicated by these results.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17060026     DOI: 10.1080/08916930600907954

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  35 in total

Review 1.  PKC-θ is a drug target for prevention of T cell-mediated autoimmunity and allograft rejection.

Authors:  Myung-Ja Kwon; Ruiqing Wang; Jian Ma; Zuoming Sun
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2010-12       Impact factor: 2.895

2.  PKC-θ: hitting the bull's eye.

Authors:  Michael L Dustin
Journal:  Nat Immunol       Date:  2011-10-19       Impact factor: 25.606

3.  GWAS analysis using interspecific backcross progenies reveals superior blue catfish alleles responsible for strong resistance against enteric septicemia of catfish.

Authors:  Suxu Tan; Tao Zhou; Wenwen Wang; Yulin Jin; Xiaozhu Wang; Xin Geng; Jian Luo; Zihao Yuan; Yujia Yang; Huitong Shi; Dongya Gao; Rex Dunham; Zhanjiang Liu
Journal:  Mol Genet Genomics       Date:  2018-05-08       Impact factor: 3.291

4.  The nuclear orphan receptor NR2F6 suppresses lymphocyte activation and T helper 17-dependent autoimmunity.

Authors:  Natascha Hermann-Kleiter; Thomas Gruber; Christina Lutz-Nicoladoni; Nikolaus Thuille; Friedrich Fresser; Verena Labi; Natalia Schiefermeier; Marei Warnecke; Lukas Huber; Andreas Villunger; Gregor Eichele; Sandra Kaminski; Gottfried Baier
Journal:  Immunity       Date:  2008-08-15       Impact factor: 31.745

5.  Protective Toxoplasma gondii-specific T-cell responses require T-cell-specific expression of protein kinase C-theta.

Authors:  Gopala Nishanth; Monika Sakowicz-Burkiewicz; Ulrike Händel; Stefanie Kliche; Xiaoqian Wang; Michael Naumann; Martina Deckert; Dirk Schlüter
Journal:  Infect Immun       Date:  2010-05-24       Impact factor: 3.441

6.  Intracellular Delivery of Anti-pPKCθ (Thr538) via Protein Transduction Domain Mimics for Immunomodulation.

Authors:  E Ilker Ozay; Gabriela Gonzalez-Perez; Joe A Torres; Jyothi Vijayaraghavan; Rebecca Lawlor; Heather L Sherman; Daniel T Garrigan; Amy S Burnside; Barbara A Osborne; Gregory N Tew; Lisa M Minter
Journal:  Mol Ther       Date:  2016-09-16       Impact factor: 11.454

Review 7.  Advances in immunosuppression for renal transplantation.

Authors:  Antoine Durrbach; Helene Francois; Severine Beaudreuil; Antoine Jacquet; Bernard Charpentier
Journal:  Nat Rev Nephrol       Date:  2010-02-02       Impact factor: 28.314

Review 8.  The yin and yang of protein kinase C-theta (PKCθ): a novel drug target for selective immunosuppression.

Authors:  Elizabeth Yan Zhang; Kok-Fai Kong; Amnon Altman
Journal:  Adv Pharmacol       Date:  2013

9.  Signal Transduction in Immune Cells and Protein Kinases.

Authors:  Monica Neagu; Carolina Constantin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  Substance P promotes expansion of human mesenteric preadipocytes through proliferative and antiapoptotic pathways.

Authors:  Kara Gross; Iordanes Karagiannides; Thomas Thomou; Hon Wai Koon; Collin Bowe; Ho Kim; Nino Giorgadze; Tamara Tchkonia; Tamara Pirtskhalava; James L Kirkland; Charalabos Pothoulakis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-03-12       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.